By Michael Smith, Senior Staff Writer, MedPage Today Published: October 31, 2007 Reviewed by Zalman S. Agus, MD; Emeritus Professor at the University of Pennsylvania School of Medicine.

LOS ANGELES, Oct. 31 — Younger men with prostate cancer benefit just as much from brachytherapy as older men, a researcher said here.Younger age is often thought to predict a worse outcome after radiation, but for radioactive seed implants that’s not true, according to Alice Ho, M.D., of the Memorial Sloan-Kettering Cancer Center in New York. Dr. Ho conducted the study at New York’s Mount Sinai Medical Center. Action Points   PLEASE post a comment below Name (required) Mail (will not be published) (required) Website Categories Cancer Options Coping with Cancer Featured News Uncategorized Subscribe All posts by all authors Enter your email address: Comments (RSS) Random Posts & Pages Urologic Oncology Institute Launched To Offer Multi-Disciplinary Care, Personalized Treatments To Patients Urologic Oncology Institute Launched To  Offer Multi-Disciplinary Care, Personalized Treatments To Patients UCLA has launched a first-of-its-kind, patient-centered institute dedicated to developing leading-edge therapies for the treatment of kidney, bladder, testicular and prostate cancers. The Institute of Urologic Oncology at UCLA challenges the traditional model of academic departments operating independently of each other, Privacy Policy IsoRay Medical, Inc. Privacy Policy IsoRay Medical, Inc. is committed to protecting your privacy.  This Privacy Policy (this "Policy") describes certain policies of IsoRay Medical, Inc. and its affiliates (“IsoRay,” “we” or “us”) with respect to its collection and use of certain information.  This Policy applies to personal information collected by us De Niro Beats Prostate Cancer Suit A Los Angeles judge on Tuesday granted the actor's request to toss a lawsuit filed against him by an insurance company that claimed De Niro intentionally withheld that he had prostate cancer before the insurer signed on to cover one of his films. Fireman's Fund Insurance Co. insured the production of Newest isotope used in brachytherapy for prostate cancer FOR IMMEDIATE RELEASE: July 20, 2007 Scientific abstracts on the newest isotope used in brachytherapy for prostate cancer--IsoRay Medical’s Proxcelan™ with Cesium-131--presented at the American Association of Physicists in Medicine (AAPM) annual conference, July 22-26 RICHLAND, Washington - Noted medical researchers from around the country will gather at the New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading New Prostate Cancer Marker In Urine Indicates Whether Cancer Is Spreading ScienceDaily (Feb. 12, 2009) — Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading. In experiments reported in the journal Nature, the 5 Ways to Reduce the Risk of Prostate Cancer Prostate cancer is one of the leading killers of men. The National Cancer Institute estimates that 186,320 men will be diagnosed with prostate cancer this year, and 28,660 will die from it. Although it’s one of the most common cancers suffered by men, there are ways to minimize the risk New Urine Test Better Detects Prostate Cancer An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.The researchers say a Chemo Break Benefits Some Men With Prostate Cancer FRIDAY, Feb. 29 (HealthDay News) -- Some men with advanced prostate cancer can safely take a break from chemotherapy, says a study by researchers at the Oregon Health & Science University Cancer Institute.The study included 250 men with metastatic, androgen-independent prostate cancer -- disease that spreads from the prostate and Scientists Develop New Prostate Cancer Cell Line Researchers at the Kimmel Cancer Center at Jefferson have established a laboratory prostate cancer cell line they believe will become a valuable research tool in both understanding and treating prostate cancer. The new prostate cancer cell line reflects how the cancer can initially be fueled by the male hormone androgen and Brachytherapy of prostate cancer treatment and sterility Posted: Sep 27th, 2009 | We'll talk about the relationship between Brachytherapy of prostate cancer treatment and sterility.Brachytherapy radiation through a direct effect or through indirect effects of free radicals was generated to destroy the DNA double-strand,Instead of splitting the tumor cells can survive longer.Generally cells in M phase and   July 2010 M T W T F S S « Jan       1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31   Recent Posts ASTRO: Breast Brachytherapy Use Outpaces Evidence MR Spectroscopy May Help Diagnose, Determine Aggressiveness Of Prostate Cancer Brachytherapy of prostate cancer treatment and sterility ASTRO: Brachytherapy Called Prostate Cancer Option for Younger Men All About Robot-Assisted Prostate Surgery Contact Us Lori Woods 350 Hills Street, Suite 106 Richland, WA 99354 Phone (509) 375-1202 Email: info@canceroptions.org Legal Notices Privacy Policy